United Arab Emirates - Re-Export of Penicillins or Streptomycins Not in Dosage Forms
Since 2014, United Arab Emirates Re-Export of Penicillins or Streptomycins Not in Dosage Forms rose 18.9% year on year. In 2019, the country was ranked number 4 comparing other countries in Re-Export of Penicillins or Streptomycins Not in Dosage Forms with $28,682.16. United Arab Emirates is overtaken by Saudi Arabia, which was ranked number 3 with $75,525.71 and is followed by Yemen with $26,317. New Zealand topped the ranking with $476,039.52 in 2019, that is -2.3% compared to 2018. Guyana recorded the best 5 years average growth at +152% per year, while United States was the worst growing country at -25.7% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2019 | 28,682.16 |
| 2018 | 11,993.65 |
| 2017 | 60,109.99 |
| 2016 | 78,965.93 |
| 2015 | 46,300.02 |
Download all data from 2005 to 2019
How does United Arab Emirates rank in Re-Export of Penicillins or Streptomycins Not in Dosage Forms?
| # | 11 Countries | US Dollars | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
New Zealand
|
476,039.52 | 2019 | -2.3 % | -7.7 % | View data |
| 2 |
#2
United States
|
108,118.00 | 2019 | -33.5 % | -25.7 % | View data |
| 3 |
#3
Saudi Arabia
|
75,525.71 | 2019 | -63.2 % | NA | View data |
| 4 |
#4
United Arab Emirates
|
28,682.16 | 2019 | +139.1 % | +18.9 % | View data |
| 5 |
#5
Yemen
|
26,317.00 | 2015 | +2,726.8 % | NA | View data |